Published in Adv Nutr on May 15, 2017
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA (2006) 7.09
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry (2012) 2.13
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol (2007) 1.92
Gestational vitamin D and the risk of multiple sclerosis in offspring. Ann Neurol (2011) 1.85
25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler (2005) 1.53
Effect of high dose vitamin D intake on interleukin-17 levels in multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial. J Neuroimmunol (2015) 1.49
Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr (2007) 1.48
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry (2005) 1.42
Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol (2007) 1.41
Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial. Mult Scler (2012) 1.30
Complementary and alternative medicine for multiple sclerosis. Mult Scler (2008) 1.17
Sodium intake is associated with increased disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry (2014) 1.12
Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis. PLoS One (2010) 1.08
Multiple sclerosis and lifestyle factors: the Hordaland Health Study. Neurol Sci (2005) 1.07
Dietary intake of vitamin D during adolescence and risk of multiple sclerosis. J Neurol (2010) 1.04
Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids (2005) 1.04
Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial. Trials (2012) 1.00
The influence of nutritional factors on the prognosis of multiple sclerosis. Nat Rev Neurol (2012) 0.97
Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why? Complement Ther Med (2009) 0.97
Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis. Prostaglandins Leukot Essent Fatty Acids (2009) 0.96
Seasonal variation of nutrient intake in pregnancy: effects on infant measures and possible influence on diseases related to season of birth. Eur J Clin Nutr (2007) 0.93
The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis. Nutr Neurosci (2014) 0.92
Association of fish consumption and Ω 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis. Int J Neurosci (2013) 0.92
Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients. Lipids Health Dis (2010) 0.91
Nutrition facts in multiple sclerosis. ASN Neuro (2015) 0.91
May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach. Autoimmune Dis (2011) 0.90
Sun exposure, vitamin D and age at disease onset in relapsing multiple sclerosis. Neuroepidemiology (2010) 0.89
Vitamin B(12) Deficiency and Multiple Sclerosis; Is there Any Association? Int J Prev Med (2012) 0.86
Dietary patterns in clinical subtypes of multiple sclerosis: an exploratory study. Nutr J (2009) 0.86
Caffeine and alcohol intakes have no association with risk of multiple sclerosis. Mult Scler (2012) 0.85
Can vitamin D supplementation prevent bone loss in persons with MS? A placebo-controlled trial. J Neurol (2011) 0.85
Homocysteine, vitamin B12 and folate levels in Iranian patients with Multiple Sclerosis: a case control study. Clin Neurol Neurosurg (2013) 0.84
Not too late to take vitamin D supplements. Ann Neurol (2014) 0.83
Complementary and alternative medicine: is there a role in multiple sclerosis? Curr Neurol Neurosci Rep (2006) 0.83
Dietary pattern and risk of multiple sclerosis. Iran J Neurol (2012) 0.82
Vitamin D, pregnancy, breastfeeding, and postpartum multiple sclerosis relapses. Arch Neurol (2010) 0.82
Is malnutrition a problem for multiple sclerosis patients? J Clin Neurosci (2014) 0.80
Serum vitamin B12, folate, and homocysteine levels and their association with clinical and electrophysiological parameters in multiple sclerosis. J Clin Neurosci (2009) 0.80
Complementary and alternative medicine use and nutrient intake among individuals with multiple sclerosis in the United States. J Community Health (2015) 0.79
Nutritional status and anthropometric measurements of patients with multiple sclerosis. Saudi Med J (2012) 0.79
Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial. Am J Clin Nutr (2015) 0.78
Impact of Vitamin A Supplementation on Disease Progression in Patients with Multiple Sclerosis. Arch Iran Med (2015) 0.77
Effects of a low-fat diet with antioxidant supplementation on biochemical markers of multiple sclerosis long-term care residents. Nutr Hosp (2013) 0.77
Does lipoic acid consumption affect the cytokine profile in multiple sclerosis patients: a double-blind, placebo-controlled, randomized clinical trial. Neuroimmunomodulation (2014) 0.77
The Effect of Vitamin A Supplementation on FoxP3 and TGF-β Gene Expression in Avonex-Treated Multiple Sclerosis Patients. J Mol Neurosci (2015) 0.77
Comparison of vitamin D3 serum levels in new diagnosed patients with multiple sclerosis versus their healthy relatives. Acta Med Iran (2013) 0.77
Comparison of Antioxidant Status and Vitamin D Levels between Multiple Sclerosis Patients and Healthy Matched Subjects. Mult Scler Int (2014) 0.76
Erythrocyte membrane fatty acids in multiple sclerosis patients and hot-nature dietary intervention with co-supplemented hemp-seed and evening-primrose oils. Afr J Tradit Complement Altern Med (2013) 0.76
Several food items and multiple sclerosis: A case-control study in Ahvaz (Iran). Iran J Nurs Midwifery Res (2014) 0.76
Activity of liver enzymes in multiple sclerosis patients with Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention. Complement Ther Med (2014) 0.76